Literature DB >> 1115221

Acceleration of amyloidosis by syngeneic spleen cells from normal donors.

M Axelrad, R Kisilevsky, S Beswetherick.   

Abstract

Intravenous administration of syngeneic spleen cells from normal donors was found to markedly shorten the induction time for casein-associated splenic amyloid diposition in the mouse. The effect of intravenous donor cells seemed purely one of acceleration; it did not provoke amyloid deposition either by itself or in combination with independently ineffective heterologous proteins. The accelerator effect did not depend on the viability of the cell suspension, and after physical disruption of the cells all the accelerator activity seemed localized to the sedimentable fraction of damaged cells, nuclei and coarse debris. It is suggested that the accelerator acts through affecting the function of perifollicular splenic macrophages.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115221      PMCID: PMC1912467     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  10 in total

Review 1.  Current concepts of amyloid.

Authors:  E C Franklin; D Zucker-Franklin
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

2.  Amino acid sequence of an amyloid fibril protein of unknown origin.

Authors:  D Ein; S Kimura; W D Terry; J Magnotta; G G Glenner
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

3.  Transfer amyloidosis. Studies on the nature of the amyloid inducing factor in a murine transfer system.

Authors:  F Hardt; P Hellung-Larsen
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

4.  Experimental murine amyloidosis in x-irradiated recipients of spleen homogenates or serum from sensitized donors.

Authors:  D T Janigan; R L Druet
Journal:  Am J Pathol       Date:  1968-02       Impact factor: 4.307

5.  Amino acid sequence of monkey amyloid protein A.

Authors:  M A Hermodson; R W Kuhn; K A Walsh; H Neurath; N Eriksen; E P Benditt
Journal:  Biochemistry       Date:  1972-08-01       Impact factor: 3.162

6.  [Experimental amyloidosis produced by transplanting viable splenic cells].

Authors:  R Dreher; E Letterer
Journal:  Virchows Arch B Cell Pathol       Date:  1970

7.  Experimental amyloidosis. Role of antigenicity and rapid induction.

Authors:  D T Janigan; R L Druet
Journal:  Am J Pathol       Date:  1966-06       Impact factor: 4.307

8.  The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils.

Authors:  M Levin; E C Franklin; B Frangione; M Pras
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  New, third class of amyloid fibril protein.

Authors:  G Husby; J B Natvig; K Sletten
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

10.  Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.

Authors:  M Levin; M Pras; E C Franklin
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

  10 in total
  5 in total

Review 1.  Inflammation-associated amyloidogenesis. Lessons for Alzheimer's amyloidogenesis.

Authors:  R Kisilevsky
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

2.  Effects of amyloid induction on plasma protein turnover, and its implication.

Authors:  R Kisilevsky; M Axelrad; S Brunet; M Richards
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

3.  Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.

Authors:  Masatoshi Omoto; Tadaaki Yokota; Dan Cui; Yoshinobu Hoshii; Hiroo Kawano; Toshikazu Gondo; Tokuhiro Ishihara; Takashi Kanda
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

4.  Experimental systemic amyloidosis induced by immunization with syngeneic organ extracts in mice.

Authors:  Y Mori; B Akikusa; T Mori; S Ueda; K Iesato; H Yoshida; M Ogawa; I Kato; Y Wakashin; M Wakashin
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

Review 5.  Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting.

Authors:  Robert Kisilevsky; Sara Raimondi; Vittorio Bellotti
Journal:  Front Mol Biosci       Date:  2016-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.